Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silybin Supplementation in HCV Therapy
NCT01957319Phase 3Completed
- Sponsor
- University of Catania
- Start
- Feb 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silibinin in major depressive disorder (MDD), anxiety disorder, sponsored by University of Catania. Started Feb 2010; status: completed.
02
Drugs
silibinin
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT01957319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957319.